Watermark
Go to Asia edition

AB InBev has few options after pulling Asian IPO

Anheuser-Busch InBev’s decision to pull the $9.8bn IPO of its Asian business is a classic example of a seller not listening to the views of investors when it comes to valuation.

  • By Aidan Gregory
  • 18 Jul 2019

Buyers shunned the IPO because they thought the $54.2bn-$63.7bn valuation AB InBev was seeking for the division was far too expensive.

Despite equity markets being at, or near, all-time highs, there have been outflows from funds. Sellers need to understand that investors do not think that this rally ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial
Log in

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bond Comments

All International Bonds

Rank Lead Manager Amount $bn No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Citi 46.13 158 8.70%
2 JPMorgan 39.39 148 7.43%
3 BofA Securities 30.92 124 5.83%
4 Barclays 30.15 121 5.68%
5 Goldman Sachs 25.25 89 4.76%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $bn No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 HSBC 0.69 5 11.54%
2 Goldman Sachs 0.65 3 10.82%
3 BofA Securities 0.59 5 9.79%
4 Credit Suisse 0.54 4 9.02%
5 Citi 0.37 3 6.24%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $bn No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Morgan Stanley 1.17 7 11.86%
2 JPMorgan 1.06 8 10.76%
3 Citi 0.98 7 9.96%
4 Goldman Sachs 0.84 4 8.57%
5 Barclays 0.78 8 7.88%